Medicine and Dentistry
Obesity
100%
Patient
60%
Vasodilator Agent
49%
Endothelin 1
38%
Metabolic Syndrome
38%
Inpatient
35%
Vasodilatation
30%
Acetylcholine
28%
Sodium Nitroprusside
25%
Adipose Tissue
17%
Endothelial Dysfunction
17%
Nitric Oxide
17%
Cardiovascular Disease
17%
Cardiovascular Risk
16%
Therapeutic Procedure
16%
Maturity Onset Diabetes of the Young
16%
Hyperinsulinemia
15%
Gastrointestinal Hormone
14%
Vasoconstriction
14%
Insulin Resistance
13%
Receptor
13%
Osteoprotegerin
13%
Blood Vessel Reactivity
13%
Development
12%
Serositis
12%
Combination Therapy
12%
Oxidative Stress
12%
BQ-123
11%
Artery
11%
Endothelin
11%
Cardiovascular System
11%
Homeostasis
10%
Tumor Necrosis Factor
10%
Hypertension
10%
Forearm Blood Flow
9%
Atherosclerosis
9%
Plaque
9%
Gut
9%
Diabetes
9%
Exercise
8%
Diseases
8%
Hypercholesterolemia
8%
Acute Coronary Syndrome
8%
Essential Hypertension
8%
Glucose
8%
Drug
8%
Chemotherapeutic Agent
8%
Antidiabetic Agent
8%
Endothelial Function
8%
Patient with Obesity
7%
Pharmacology, Toxicology and Pharmaceutical Science
Obesity
77%
Metabolic Syndrome X
42%
Vasodilator Agent
38%
Endothelin 1
34%
Insulin
28%
Diabetes Mellitus
21%
Nitric Oxide
18%
Acetylsalicylic Acid
17%
Nitroprusside Sodium
17%
Acetylcholine
16%
Hyperinsulinemia
14%
angiotensin[1-7]
14%
Cardiovascular Risk
10%
Insulin Resistance
10%
Endothelin
10%
Bioavailability
9%
Gastrointestinal Hormone
8%
Hypercholesterolemia
8%
Complication
8%
Glucose
8%
Metabolic Disorder
7%
Diseases
7%
Vasoconstrictor Agent
7%
Drug
7%
Glucagon-Like Peptide-1
6%
Blood Vessel Injury
6%
Osteoprotegerin
5%
Leptin
5%
Ghrelin
5%
Epoxyicosatrienoic Acid
5%
Breast Cancer
5%
Colchicine
5%
Canagliflozin
5%
Familial Mediterranean Fever
5%
Glucagon
5%
Mirabegron
5%
Endothelial Dysfunction
5%
Endothelin
5%
Ascorbic Acid
5%
Non Insulin Dependent Diabetes Mellitus
5%
Malignant Neoplasm
5%
Fasudil
5%
Absence
5%
Endothelial Dysfunction
5%
Biochemistry, Genetics and Molecular Biology
Endothelin 1
19%
Glucose
10%
Human
10%
Development
10%
Insulin
10%
Oxidative Stress
9%
Clinical Trial
7%
Vasoconstriction
7%
Vasodilatation
7%
Nitric Oxide
7%
Dyslipidemia
6%
Prevalence
6%
TLR4
5%
Obestatin
5%
Tandem Mass Spectrometry
5%
Body Mass
5%
Fractalkine
5%
Gas Chromatography-Mass Spectrometry
5%
Cholesterol
5%
Glucagon
5%
High-Density Lipoprotein
5%
Sample
5%
Health
5%
Blood Pressure
5%
Ceramide
5%
Metabolomics
5%
Hyperglycemia
5%
Glucose Level
5%
Liquid Chromatography-Mass Spectrometry
5%
Sphingolipid
5%
LCN2
5%
Insulin Resistance
5%
